2 Methyl-thieno-benzodiazepine lyophilized formulation
OwnerKurt Douglas Dekemper, Alan Lee Fites +1inventors
InventorsKurt Douglas Dekemper, Alan Lee Fites, Steven LaMar Nail
Life of this patent
Estimating the term…
Abstract
The invention provides an amorphous, lyophilized, parenteral formulation of olanzapine.
Claims35
A stable, amorphous, lyophilized, parenteral formulation comprising olanzapine as an active ingredient, a solubilizer and a stabilizer.
A formulation comprising olanzapine, tartaric acid, and a stabilizer.
A formulation comprising from about 1 to about 20 mg/mL olanzapine, from about 22.5 to 50 mg/mL of lactose monohydrate and from about 0.35 to 10 mg/mL of tartaric acid.
A formulation comprising from about 1 to about 20 mg/mL olanzapine, from about 20.0 to 50 mg/mL of lactose monohydrate and from about 0.35 to 10 mg/mL of tartaric acid.
A formulation obtainable by a process which comprises, lyophilization of a solution comprising olanzapine, a solubilizer, and a stabilizer.
A process for preparing a formulation which comprises, lyophilization of a solution comprising olanzapine, a solubilizer, and a stabilizer.
Dependencies are inferred from the claim text.